Hochschulschrift
Modulation of the glucose metabolism of cultured brain cells by metformin or tyrphostin 23
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
xviii, 201 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält Sonderabdrucke
Universität Bremen, Dissertation, 2017
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Schlagwort
-
Gehirn
Zentralnervensystem
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2017
Ähnliche Objekte (12)
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Formaldehyde metabolism and formaldehyde-induced alterations in glucose and glutathione metabolism of cultured brain cells
Formaldehyde Metabolism and Formaldehyde-induced Alterations in Glucose and Glutathione Metabolism of Cultured Brain Cells
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Effects of xenobiotics on the glutathione and glucose metabolism of cultured brain astrocytes
Effects of antiretroviral drugs on the glutathione and glucose metabolism of cultured brain cells
Effects of Antiretroviral Drugs on the Glutathione and Glucose Metabolism of Cultured Brain Cells
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Molecular impact of metformin on hepatocellular metabolism
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Formaldehyde metabolism and formaldehyde-induced alterations in glucose and glutathione metabolism of cultured brain cells
Formaldehyde Metabolism and Formaldehyde-induced Alterations in Glucose and Glutathione Metabolism of Cultured Brain Cells
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Effects of xenobiotics on the glutathione and glucose metabolism of cultured brain astrocytes
Effects of antiretroviral drugs on the glutathione and glucose metabolism of cultured brain cells
Effects of Antiretroviral Drugs on the Glutathione and Glucose Metabolism of Cultured Brain Cells
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Molecular impact of metformin on hepatocellular metabolism
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism
Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Formaldehyde metabolism and formaldehyde-induced alterations in glucose and glutathione metabolism of cultured brain cells
Formaldehyde Metabolism and Formaldehyde-induced Alterations in Glucose and Glutathione Metabolism of Cultured Brain Cells
Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism
Effects of xenobiotics on the glutathione and glucose metabolism of cultured brain astrocytes
Effects of antiretroviral drugs on the glutathione and glucose metabolism of cultured brain cells
Effects of Antiretroviral Drugs on the Glutathione and Glucose Metabolism of Cultured Brain Cells
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Molecular impact of metformin on hepatocellular metabolism
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism